New Published Research Finds Improvement in Liver Function in Patient with Primary Biliary Cirrhosis SHENZHEN, China, July 3, 2012 /PRNewswire-Asia/ — A study conducted by Beike Biotechnology Company (https://www.beikebiotech.com) in…
New Study Finds Cord Blood-derived Stem Cell Treatments Improve Ataxia Patients’ Functionality and Quality of Life
In an Open Label Treatment Study 30 Patients with the Neurodegenerative Disorder Hereditary Ataxia Were Treated with Stem Cells Provided by Beike Biotechnology SHENZHEN, China and SAN DIEGO, Calif., Sept….
Beike Biotechnology Upgrades Its Processing and Cryopreservation Technology to Expedite Advancements in Stem Cell Therapies
Beike and ThermoGenesis Intend to Establish a “Center of Excellence” Showcase in Taizhou City TAIZHOU, China, March 16, 2011 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd. (“Beike”) (https://www.beikebiotech.com), China’s leading stem…
ThermoGenesis Announces Agreement for AXP and BioArchive Cord Blood Systems With Major Chinese Stem Cell Company
RANCHO CORDOVA, Calif., Feb. 10, 2011 /PRNewswire/ — ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today it…
Beike Biotechnology and Medistem, Inc. Report on 114 Patients Treated With Novel Cord Blood Stem Cell Protocol; New Approach Opens Door to Expanded Uses of Cord Blood Stem Cells SHENZHEN,…
New Center Integrates Traditional Chinese, Romanian and Western Therapies CAMPINA and PRAHOVA, Romania, July 20 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd. (https://www.beikebiotech.com/index.php ), one of the world’s leading biotechnology companies…